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Abstract:  
Aims: We looked for the factors which can be adjust in order to reduce the frequency and severity 
of  diabetic retinopathy in Maramureş County, Romania.  
Methods: We done a cross-sectional study of 1269 persons with diabetes mellitus registered in the 
healthcare system in Maramureş. The signs of diabetic retinopathy were ascertained from retinal 
digital photographs. We analyzed different parameters: demographics (age, gender, smoking status, 
alcohol use, living areas, socioeconomic status); physical measurements (body mass index BMI, 
abdominal circumference); laboratory measurements (glycemic control, lipid profile, the degree of 
proteinuria) diabetes characteristics (duration, type, other complications) and characteristics of 
comorbid diseases. 
Results: The total number of patients with retinopathy was 246. From these 94 (38.2%) have mild 
non proliferative diabetic retinopathy (NPDR) 78 (31.7%) have moderate NPDR, 52 (21.1%) have 
severe NPDR and 22 (9.0%) have proliferative diabetic retinopathy (PDR). Among our patients 
3.2% had maculopathy (0.6% mild, 0.6% moderate and 2.0% severe). The risk factors associated 
with severity of retinopahy were: diabetes duration (p=0.000), HbA1c (p=0.005), presence of 
nephropathy (p=0.004), presence of polineuropathy (p=0.002). Risk factors associated with severity 
of maculopathy was presence of nephropathy (p=0.000). 
Conclusions: A positive correlation between diabetes duration and diabetes control and severity of 
retinopathy was found. Severity of retinopathy was higher in the presence of nephropathy and 
polineuropathy. Severity of maculopathy was higher in the presence of nefropathy. 
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Introduction 
There is an enormous increase in the worldwide prevalence of diabetes. It was estimated that 
more than 250 people around the world have diabetes and it is expected to rise to 380 million 
within 20 years [1]. An individual’s risk is defined by the presence of both genetic and 
environmental factors. The diabetic retinopathy is the most frequent complication of this burden 
“epidemic disease”. 
UKPDS [2], a landmark study in type 2 diabetes, and similar DCCT [3], a remarkable study in 
type 1 diabetes established the importance of blood glucose control and blood pressure control in 
reducing the risk of diabetic retinopathy. This established that for a 1% decrement in HbA1c a 31% 
lower reduction of retinopathy [3]. Similar findings came from Steno-2 Study [4]. Lipid-lowering 
agents are widely associated in this disease [5]. While hard exudates and macular oedema are often 
associated with high lipid levels, lipid-lowering agents may be a therapeutic option for the treatment 
of this complication [6].  Any improvement in management of this disease has a major contribution 
in reduction of microvascular complications. MOCIRAN Mihaela, DRAGOS Cristian, and HÂNCU Nicolae 
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Therefore we looked for the factors which can be adjust in order to reduce the frequency and 
severity of diabetic retinopathy. There are few data about our patients, the patient in Maramureş 
County, the northeast part of Romania. 
Material and Method 
All individuals with diabetes registered in the county diabetes register in the region of 
Maramures at the end of the year 2007 were included in the study. We analysed retrospective the 
hospital documents, individual records and any other medical notes. All individuals gave oral 
informed consent for to use their dates. The study followed the recommendations of the 
Declaration of  Helsinki. 
 
Baseline variables 
Variables: age, gender, cigarette smoking (present or absent), alcohol consumption (never, 
occasionally, chronic), areas (urban or rural), socioeconomic status (good, medium, poor) were 
obtained from the hospital records or any other medical notes. 
Diabetes and its complications data (as type, duration, medications, complications (peripheral 
neuropathy- presence or absence; autonomic neuropathy - presence or absence, diabetic 
nephropathy - presence or absence; peripheral vascular disease - presence or absence)) were 
obtained from the hospital records. 
Concomitant disease: presence or absence of hypertension and other cardiovascular diseases 
(heart attacks, cerebrovascular disease, rheumatic heart disease, congenital heart disease, heart 
failure), hyperlipidemia, any other concomitant disease were obtained from the hospital records 
(steatohepatitis, hypothyroidism, hyperthyroidism, rheumatic disease etc).  
Physical measurement: height without shoes (in m), weight in light clothing (in kg) and waist 
circumference (in cm). Body mass index (BMI) was calculated: weight(kg)/height2 (m²). Laboratory 
measurements: Glycosylated hemoglobin (HbA1c) (%) (normal < 7%), total cholesterol (mg/dl) 
â(normal < 180 mg/dl), HDL-cholesterol (mg/dl) (normal HDL > 40 mg/dl in men and >50 
mg/dl in women) , triglycerides (mg/dl) (normal < 150mg/dl) from fasting blood samples 
measured in local laboratories. Total cholesterol was measured by an enzymatic colorimetric 
cholesterolesterase method, triglycerides were measured by an enzymatic colorimetric 
glycerophosphatoxidase method and HDL was measured by direct enzymatic determination 
(analyser ACCENT 300). 
Kidney function was assessed by calculating the estimated Glomerular Filtration Rate (GFR) 
using Modification of Diet in Renal Disease (MDRD). Study equation GFR 
(mL/min/1.73m2)=175 × (serum creatinine) - 1.154 × (Age) - 0.203 × (0.742 if female ) × (1.212 
if African American) [7]. We measured the degree of proteinuria and estimate diabetic nephropathy: 
microalbuminuria (urinary albumin excretion rate of 30-300 mg/24) for incipient nephropathy and 
macroalbuminuria (urinary albumin excretion more than 300 mg/24 h). It was used colorimetric 
methods by pyrogallol (analyser ACCENT 300). 
Retinal digital photography (auto fundus camera Nidek AFC-210, CE marked) was performed 
at the end of the examination after medical dilatation of the pupil. We used Standard Internal 
Fixation, with three positions, the center of the captured image being selected among the macula, 
the papilla and the midpoint between the macula and papilla. Each of the six digital photographs 
was graded by greatest degree in any field for the macula and retina separately. Overall retinopathy 
and maculopathy levels were assessed based on the International Clinical Diabetic Retinopathy and 
Diabetic Macula Edema Disease Severity Scale [8] for each patient based on the grading score of 
the worse eye: none, non proliferative diabetic retinopathy (NPDR) (mild, moderate, severe) and 
proliferative diabetic retinopathy (PDR). In addition, the presence and severity of maculopathy 
(none, mild, moderate or severe) was identified and recorded. In some unclear or severe situations, 
we referred the patients to an ophthalmologist for further evaluation and treatment. 
Inclusion Criteria: pacients with diabetes mellitus registered in Diabetes Center from Maramureş 
County. We excluded patients with history of laser treatment, patients with cataract or other Risk Factors and Severity of Diabetic Retinopathy in Maramures
 
49 
diseases which may affect the quality of digital photography, patients with severe mental diseases, 
patients whose medical records didn’t contain  all the dates describe above. 
Statistics 
The ordered multinomial logit model was used in order to evaluate the possibility of having 
diabetic retinopathy in relation to the risk factors: diabetes type, diabetes duration, HbA1c, 
cholesterol, triglycerides, HDL, nephropathy, polineuropathy, peripheral vascular disease 
hyperlipidemia, cardiovascular disease, hypertension, BMI, abdominal circumference, alcohol, 
smoke, age, gender, medium, socioeconomic conditions. For these estimations, we used STATA 
software package version 9.1. 
Results 
From a total of 12917 registered patients with diabetes only 1269 were available for analysis 
(the rest were excluded because we did not have all the dates for analyses as mentioned above). The 
sample was representative, the prevalence of the retinopathy having a confidence interval of 
± 2.1% for a 0.05 p-value. The results of the logit model in analysis of risk factors for diabetic 
retinopathy is presented in Table 1 and for maculopathy in Table 2. 
Table 1. Risk factors for diabetic retinopathy types 
  Diabetic retinopathy type (ordered multinomial logit model) 
 coef. p-value 
Diabetes type  -0.033272  0.935 
Diabetes duration  0.101247  0.000*** 
HbA1c 0.117456  0.005*** 
Cholesterol -0.000688  0.724 
Triglycerides -0.001066  0.135 
HDL 0.008627  0.113 
Nephropathy 0.829131  0.004*** 
Hyperlipidemia -0.033934  0.718 
Cardiovascular disease  -0.397895  0.053* 
Hipertension 0.350344  0.065 
BMI -0.058148 0.009*** 
Abdominal circumferince  0.016371  0.077 
Alchool -0.026031  0.845 
Smoke -0.019123  0.930 
Age   -0.000014  0.999 
Gender 0.110966  0.512 
Medium 0.291435  0.070* 
Socioeconomic conditions  0.046626  0.693 
Polineuropathy 0.644894  0.002*** 
Peripheral vascular disease   -0.784258  0.296 
N=1269,  Pseudo R2 = 0.0692 
LR
2 χ (20)=141.80  (p<0.001) 
*significant at 10%, **significant at 5%, ***significant at 1% 
 
The total number of patients with retinopathy was 246. From these 94 (38.2%) have mild 
NPDR, 78 (31.7%) have moderate NPDR, 52 (21.1%) have severe NPDR and 22 (9.0%) have 
PDR. Among our patients 3.2% had maculopathy (0.6% mild, 0.6% moderate and 2.0% severe). 
The prevalence of retinopathy in relation with diabetes duration was presented in Table 3. 
Regarding maculopathy in relation with diabetes duration we found the results presented in 
Table 4. 
The prevalence disbtribution of retinopathy in relation with HBA1c is presented in Table 
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Table 2. Risk factors for diabetic maculopathy types 
  Diabetic maculopathy type (ordered multinomial logit model) 
 coef.  p-value 
Diabetes  type  0.087442  0.912 
Diabetes duration  0.061536  0.022** 
HbA1c 0.225284  0.011** 
Cholesterol 0.011612  0.008*** 
Triglycerides -0.004936  0.050*** 
HDL 0.004647  0.709 
Nefropathy 1.956632  0.000*** 
Hiperlipidemia -0.423629  0.332 
Cardiovascular diseases  -0.304823  0.506 
Hipertension 0.270929  0.541 
BMI -0.058140  0.301 
Abdominal circumferince  -0.011453  0.592 
Alchool 0.492044  0.097* 
Smoke -0.086044  0.861 
Age 0.016946  0.420 
Gender   -0.183224  0.629 
Medium   0.388188  0.295 
Socioeconomic conditions  0.191850  0.465 
Polineuropathy 0.893494  0.029** 
Peripheral vascular disease  -40.996200  0.999 
N=1269,  Pseudo R2 =  0.1456 
LR
2 χ (20)=62.81  (p<0.001) 
*significant at 10%, **significant at 5%, ***significant at 1% 
Table 3. The prevalence of retinopathy in relation with diabetes duration (%) 
Retinopathy type (%)    
NPDR 
mild 
NPDR 
moderate 
NPDR 
severe 
PDR Total 
below 5  4.6  3.9 3.0 0.9  12.4 
from 5 to 10  9.7  6.4  4.3  1.8  22.2 
from 10 to 15  11.5 14.2  7.1  4.4  37.2 
Diabetes 
duration 
(years) 
over 15  22.2 30.6  11.1  6.3  70.2 
Table 4. The prevalence of maculopathy in relation with diabetes duration (%) 
Maculopathy type (%)   
mild moderate Severe total 
below 5  0.65 0.79  1.57  3.01 
from 5 to 10  0.61 0.61  1.82  3.04 
from 10 to 15  0.88 0.00  2.65  3.53 
Diabetes 
duration 
(years) 
over 15  0.00 0.00  4.76  4.76 
Table 5. The prevalence of retinopathy in relation with HBA1c 
DR type (%) 
HbA1c 
(values %)  NPDR 
mild 
NPDR 
moderate 
NPDR 
severe 
PDR DR  total 
under 7  5.4  4.5  2.9  1.0  13.8 
from 7 to 9  8.2  7.6  5.3  1.9  23.0 
over 9  11.9  7.9  5.1  3.4  28.3 
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Discussion 
In a population-based cohort followed after WESDR, Wisconsin Epidemiologic Study of 
Diabetic Retinopathy, among US adults after 4-14 years’ diabetes duration during the period 1990-
2002, the authors also observed less severe retinopathy than expected, with a very low prevalence of 
moderate–severe nonproliferative retinopathy (10 percent) and only one person with treated or 
proliferative retinopathy by 14 years' duration. In contrast, at the baseline evaluation in WESDR, 
moderate–severe nonproliferative retinopathy was found in 35 percent of persons and proliferative 
retinopathy in 25 percent of persons at 13–14 years' duration [9].  Again, the more recent 
population-based studies in Sweden and Finland reported lower levels of advanced nonproliferative 
or preproliferative retinopathy, ranging from approximately 2 percent to 5 percent [10,11]. In these 
countries the improvement in treatment was the principal argument for these decreasing in 
prevalence and severity.  
In a comparative study between France, Italy, Spain, and United Kingdom the authors find that 
the proportion of diagnosed DR ranged from 10.3% (95% CI [6.7%-14.0%]) in Spain to 19.6% 
(95% CI = [16.0%-23.1%]) in the United Kingdom and consistently across countries, mild NPDR 
was the most common severity level of diagnosed DR. PDR ranged from 19.7% (France) to 31.5% 
(UK). Diabetic macular edema was reported in approximately 10% of patients [12]. 
In our region the prevalence of moderate and severe DR was higher but the prevalence of PDR 
was lower. In our region the most prevalent disease is also mild NPDR. We can debate about the 
fact that in our country there is no screening program for DR. There are many patients who did not 
ask for medical advice or did not respect their treatment or even refused to go to specialists in 
diabetes. There are few ophthalmologists trained in diabetic retinopathy and unfortunately they are 
only in universities. 
Glycosylated hemoglobin was also strongly related to the risk of retinopathy, and the 
association was stronger at longer durations. For a 1 percent  increase in mean glycosylated 
hemoglobin level, at 4 years, the hazard of retinopathy increased by 14%, and at 7 and 9 years, the 
hazards increased by 44% and 42%, respectively [9]. 
In Chennai Urban Rural Epidemiology Study, ordinal logistic regression analysis 1715 subjects 
showed that male gender (P = 0.041), duration of diabetes (P < 0.0001), glycated haemoglobin 
(HbA(1c); P < 0.0001), macroalbuminuria (P = 0.0002) and insulin therapy (P = 0.0001) were 
significantly associated with severity of DR [13]. We also recognize that HbA1c is associated with 
severity of DR. 
A study done in Spain with 208 patients find that  patients with long standing diabetes have a 
high risk to develop diabetic maculopathy, but other closely-related risk factors are hypertension, 
hyperglycemia, lipids, tobacco smoking and renal status [14]. In a small study with only 38 patients 
the author noticed that patients with diabetic maculopathy had significantly higher values of total 
lipids, triglycerides, total cholesterol. There were no statistically significant differences for HDL 
[15]. Interesting in another study the authors find that the regression of hard exudates was most 
likely due to the aggressive lipid lowering [16]. In our study we have a small number of patients 
with diabetic maculopathy and the relation between maculopathy and cholesterol and triglycerides 
is uncertain. We need much more patients with maculopathy for significant and interpretable dates. 
Conclusions 
A positive correlation between diabetes duration and diabetes control and severity of 
retinopathy was found. Severity of retinopathy was higher in the presence of nephropathy and 
polineuropathy. Severity of maculopathy was higher in the presence of nefropathy. 
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